Supplementary Data 2 from Discovery of JNJ-63576253, a Next-Generation Androgen Receptor Antagonist Active Against Wild-Type and Clinically Relevant Ligand Binding Domain Mutations in Metastatic Castration-Resistant Prostate Cancer
التفاصيل البيبلوغرافية
العنوان:
Supplementary Data 2 from Discovery of JNJ-63576253, a Next-Generation Androgen Receptor Antagonist Active Against Wild-Type and Clinically Relevant Ligand Binding Domain Mutations in Metastatic Castration-Resistant Prostate Cancer
American Association for Cancer Research (AACR), 2023.
سنة النشر:
2023
الوصف:
Enzalutamide activates AR signaling in the absence of androgen in HepG2 transiently transfected with AR F877L and AR F877L/T878A constructs but not AR T878A only
